Pseudomonas aeruginosaas a Cause of 1,3‐β‐d‐Glucan Assay Reactivity
Open Access
- 15 June 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (12), 1930-1931
- https://doi.org/10.1086/588563
Abstract
To the Editor—The fungal component 1,3-β-d-glucan is increasingly used to diagnose invasive fungal infection in immunocompromised patients [1]. Some studies showed false-positive results (i.e., positive findings not related to invasive fungal infection) in bacteremic patients, which were not related to known causes of reactivity, such as 1,3-β-d-glucan in fungal-derived antibiotics [1–4].Keywords
This publication has 5 references indexed in Scilit:
- Linear osmoregulated periplasmic glucans are encoded by the opgGH locus of Pseudomonas aeruginosaMicrobiology, 2007
- Non–Culture-Based Diagnostics for Opportunistic FungiInfectious Disease Clinics of North America, 2006
- 1,3-β-D-Glucan in Patients Receiving Intravenous Amoxicillin–Clavulanic AcidNew England Journal of Medicine, 2006
- Evaluation of a (1→3)-β- d -Glucan Assay for Diagnosis of Invasive Fungal InfectionsJournal of Clinical Microbiology, 2005
- Serum Glucan Levels Are Not Specific for Presence of Fungal Infections in Intensive Care Unit PatientsClinical and Vaccine Immunology, 2003